The invention generally relates to method and apparatus for crossing an obstruction in a tubular member, and more particularly to a medical device method for crossing of a chronic occlusion in a subintimal or interstitial space of an artery.
Atherosclerosis is a common human ailment arising from deposition of fatty-like substance, such as atheroma, or plaque on the walls of major blood vessels. These deposits occur within the peripheral arterial system which feeds the limbs of the body and also occur within the coronary arterial system which feeds the heart. These deposits accumulate in localized areas, narrow the vascular lumen, and eventually causing restriction of normal blood flow. In some cases, the deposits result in a chronic partial or total occlusion. Such restriction can lead to a serious health risk including critical limb ischaemia. If blood flow cannot be adequately restored through surgical or endovascular intervention and the probability of limb amputation increases dramatically.
Until recently, chronic total occlusions have been treated by bypass which poses high procedural risks and is quite traumatic to the patient. Recently, catheter based intravascular procedures have been utilized. These techniques include step-by-step crossing of an occlusion using Excimer laser atherectomy devices and methods, crossing the occlusion with highly flexible and maneuverable guide wires, and other techniques known in the art. Once the lesion has been crossed, then standard endovascular devices such as laser atherectomy, angioplasty, stenting, and the like, can be used to enlarge the lumen and increase blood flow within the peripheral arterial system. These catheter-based intravascular procedures are typically preferred since they are much less traumatic to the patient, safer and cost-effective while delivering comparable long term vessel patency compared to more traumatic surgical alternatives.
Before catheter-based treatments can be used, with the exception of step-by-step Excimer laser methods, the guide wire must first pass through the total occlusion to provide access for the interventional catheter. Specifically, once a guide wire has crossed the occlusion, it can then be used as a rail to support interventional catheters. In some cases, the physician can maneuver the guide wire through the total occlusion establishing access. In many instances, the physician encounters a calcified cap on the proximal end of the occlusion and is unable to maneuver the guide wire through the cap and across a calcified or fibrous lesion. In many cases, the guide wire inadvertently penetrates the subintimal space between the intimal layer and the adventitial layer of the blood vessel as the guide wire attempts to cross the lesion. Once in the subintimal space, it is difficult to direct the guide wire back into the vessel lumen making it nearly impossible to perform a catheter based intravascular procedure.
In one related art technique, Dr. Bolia developed a revasculature procedure as described in Recanalisation of femoro-popliteal occlusions: Improving success rate by subintimal recanalisation, Clinic Radiol, 40:325, 1989, by exploiting the subintimal space where a guidewire enters the subintimal space between the intima and adventitia layers, is subsequently advanced to a point distal to the occlusion, and then maneuvered to re-enter or puncture the vessel layers to enter the true lumen of the vessel. Once the guide wire has traversed through the subintimal layer and re-enters the true lumen of the vessel at a point distal to the occlusion, percutaneous balloon angioplasty is performed to restore blood flow through subintimal recanalization. This is a highly skilled technique with a low to moderate success level of consistent re-entry at the physician's preferred location just distal to the occlusion.
There are number of other related art catheters and methods for forming lateral penetrations through tissue to and from blood vessels past total occlusions, some of these are described in U.S. Pat. Nos. 5,443,497; 5,429,497; 5,409,019; 5,287,861; 6,231,546; 6,217,527; 6,506,178; 6,221,049; 6,235,000; 6,511,458; 6,719,725; 7,004,173; and 7,179,270, all of which are incorporated by reference for teaching reentry catheters, methods and for the purpose of written description and enablement requirements. These related art methods embody penetration of a needle exiting through either a side port or through a distal port, the needle must be oriented properly to ensure that the needle, when deployed, re-enters at a preferred location distal to the occlusion. One problem with these methods is a tendency of the catheter to back out as a result of the moment imposed by force required to penetrate the subintimal layers to gain access to the vessel true lumen. This is particularly problematic in the presence of calcified lesions causing an increase in the forces necessary for successful re-entry and, in many cases, requiring the physician to re-enter at a sub-optimal location.
The invention is directed to a medical device and method thereof that substantially obviates one or more of the problems due to limitations and disadvantages of the related art.
An advantage of the invention is the reduction in the forces required to cross the subintimal layer during device reentry into the true vessel lumen due to the articulating cannula or sharp member.
Yet another advantage of the invention is the reduction in the overall required size of the device since a long rigid element is not needed at the distal tip to support large reentry forces.
Still another advantage of the invention is improved stability and control of the distal tip during deployment of the cannula or interventional wire upon reentry from the subintimal space to the true vessel lumen thereby preventing against the device backing out or further separating the intima from the adventitia.
Yet another advantage of the invention is improved trackability and control, thereby allowing a physician or operator to re-enter the true vessel lumen at their preferred location close to the distal end of the total occlusion.
Additional features and advantages of the invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learned by practice of the invention. The objectives and other advantages of the invention will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.
To achieve these and other advantages and in accordance with the purpose of the present invention, as embodied and broadly described, is to provide a method for crossing an obstruction in a blood vessel. The method includes advancing a guide wire into an interstitial space of a vessel. Next, a catheter is advanced into the subintimal space with the aid of the guide wire. This may be accomplished using a traditional over the wire approach or using a rapid exchange catheter. For example, a rapid exchange reentry catheter method and catheter is described in U.S. Patent Application Ser. No. 61/503,477, which is hereby incorporated by reference as if fully set forth herein.
In one embodiment, a second wire or the original wire in an over the wire configuration, is advanced down a central lumen of a reentry member that is configured to deploy through at least one distal port to gain access to a vessel true lumen from a subintimal space.
In a preferred embodiment, the operator activates the reentry member through either a push or pull mechanism or the deployment of a balloon to direct the sharp from the subintimal space into the vessel lumen. Through this preferred embodiment, reentry into the true lumen of a vessel is accomplished at a location immediately distal to the total occlusion. It is noted that other locations may also be used for reentry. Preferably, the reentry member is configured to exit the lateral port and into the true lumen of the vessel from the subintimal space prior to advancement of an intervention wire through the lateral port.
Another aspect of the invention is directed towards a catheter system that includes a catheter having a proximal end, a distal end, lateral port, and at least one lumen. At least one lumen extends longitudinally through at least the lateral port of the catheter. The catheter includes a reentry member which is configured to gain access to a vessel true lumen from a subintimal space. The reentry member is configured to penetrate the vessel layers adjacent to the distal port. In a preferred embodiment, the reentry member has one or more sharpened edge surfaces along a distal portion of the cutting device. The reentry member is configured to have a hollow portion to receive an interventional guide wire.
Yet another aspect of the invention is directed towards a reentry catheter for use in forming a pathway in an interstitial space of an artery. The reentry catheter includes a catheter body including a proximal end, a distal end, at least one lumen, and at least one port. An exchange port is arranged on at least a distal portion of the catheter body and the exchange port includes at least one lumen configured to receive a guidewire and the catheter body is configured to track over the guidewire to a treatment site. A reentry member is slidably arranged within the lumen of the catheter body and is configured to deploy through the catheter body port. In one embodiment, the reentry member is configured to deploy from a first location within the interstitial space of an artery to a second location within a true lumen of the artery upon application of a substantially eccentric force to a distal portion of the reentry member.
Still yet another aspect of the invention is directed towards a reentry catheter for use in forming a pathway in an interstitial space of an artery. The reentry catheter includes a catheter body having a proximal end, a distal end, at least one lumen, and at least one port. An exchange port is arranged on at least distal portion of the catheter body. The exchange port is configured to receive a guidewire and the catheter body is configured to track over the guidewire to a treatment site. A reentry member having a proximal end, a distal end, at least one lumen is configured to be slidably positioned within the lumen of the catheter body. The reentry member includes a portion having a sharp surface to permit dissection of a portion of an artery. A tether is coupled to a distal end portion of the reentry member and the reentry member is configured to deploy through the at least one port from a first location within the interstitial space of an artery to a second location within a true lumen of the artery upon application of a force to the tether.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention.
In the drawings:
The invention generally relates to a method and system for crossing an obstruction in a tubular member, e.g., crossing a chronic total occlusions in a blood vessel, and more particularly to a medical device method for crossing of an occlusion in a subintimal or interstitial space of an artery. Subintimal or interstitial region or space is at a location beneath at least a portion of intima and preferably at a location contained between the intima and the adventitia of the vessel. The terms tubular member, artery, vessel and bodily passable are used interchangeably throughout the specification.
An embodiment of invention is directed towards a catheter for insertion into a subintimal space. The catheter includes a proximal end, a distal end, at least one lateral port, and at least one lumen for receiving a guide wire. The at least one lumen extends longitudinally through at least the lateral port of the catheter. The catheter may also include an exchange port, e.g., RX port, arranged along an exterior portion of the catheter body and configured to receive a second wire or guide wire. The exchange port may be broken into two or more segments along the length of the catheter.
The catheter also includes a reentry member including at least one sharp surface and configured to operate out of a portion of the lateral port. In one embodiment, the reentry member is configured with one or more sharp surfaces near its distal end, e.g., in a tear drop cross-section configuration. Alternatively, the cutting surface may extend along the entire surface of the reentry member or only a predetermined portion. Preferably, the cutting surface is configured to gain access from the subintimal or interstitial region or space to the true lumen of the vessel. In one embodiment, the reentry member includes a lumen for receiving a guide wire or supplemental treatment device. These supplemental treatment devices may include guide wires, medical instruments, balloons, stents, laser catheters, optical fibers, visualization devices, medications and other medical instruments known in the art. In a preferred embodiment, the lumen portion of the reentry member is configured to receive a guide wire having a diameter in a range from about 0.01 inches to about 0.04 inches or larger.
In one embodiment, a catheter system includes a catheter body having a proximal end, a distal end, and at least one lumen wherein the lumen includes a lateral opening. A reentry member including at least one void space or cut out that enables flexing is formed in at least a distal portion of the reentry member. The reentry member is configured to flex from a first a position to a second position upon application of a force to a distal region of the reentry member.
In another embodiment, a reentry catheter for use in forming a pathway in an interstitial space of an artery includes a catheter body including a proximal end, a distal end, at least one lumen, and at least one port. An exchange port is arranged on at least a distal portion of the catheter body. The exchange port includes at least one lumen configured to receive a guidewire and the catheter body is configured to track over the guidewire to a treatment site. A reentry member includes a proximal end and a distal end where distal end of the reentry member is configured to deploy through the at least one port from a first location within the interstitial space of an artery to a second location within a true lumen of the artery upon application of a substantially eccentric force to a distal portion of the reentry member.
Another embodiment is directed towards a reentry catheter for use in forming a pathway in an interstitial space of an artery. The reentry catheter includes a catheter body having a proximal end, a distal end, at least one lumen, and at least one port. An exchange port is arranged on at least distal portion of the catheter body. The exchange port includes at least one lumen configured to receive a guidewire and the catheter body is configured to track over the guidewire to a treatment site. The reentry member includes a proximal end, a distal end, at least one lumen extending from the proximal end to the distal end. A tether or flexible tension member is coupled to a distal end portion of the reentry member. The tether is configured to deploy at least a portion of the reentry member through the at least one port from a first location within the interstitial space of an artery to a second location within a true lumen of the artery upon application of a force to the tether.
Suitable materials for the reentry member include but are not limited to steel, alloys, nitinol, titanium, thermoplastics, including PEEK or polyimide, and combinations thereof and the like. The reentry member may also be configured to have a predetermined shape, i.e., resilient shape, straight shape, curved shaped, memory shape, and combinations thereof.
In one embodiment, the reentry member is moveable, flexible and/or bendable from first configuration to a second configuration, e.g., a retracted position to an operative position. The movement may be achieved upon application of a force, e.g., an eccentric force applied to a portion of the reentry member. In some embodiments, the force may be generated with at least one of a tether; a control wire; a guide wire with a hook; push member; pull member; ramp; wedge; balloon; electrically activated materials, including electroactive polymers, thermo-active polymers, electroactive metals and combinations thereof.
The electrically activated materials may be activated with an electrical signal such as current or voltage as known in the art. For example, the catheter body or the reentry member may be constructed as described in U.S. Pat. No. 7,951,186, which is hereby incorporated by reference.
In other embodiments, at least a portion of the reentry member may have a load or force built into the member. For example, the reentry member may have pre-resilient shape and contained within a shroud or other structure that prevents movement. After the shroud or other structure is removed, the reentry member is released from a first position to second position.
The catheter may be constructed from various materials as known in the art. For example, the catheter may be constructed from materials, such as polyesters; polyurethanes; polyamides; polyolefins including polyethylene and polypropylene; and any copolymers thereof. Some more specific examples of suitable materials include, but are not limited to: nylon; polyester elastomer; polyether/block polyamide, such as PEBAX, Hytrel, and/or Amitel; polyamide such as Grilamid; fluoro-polymer, such as Kynar; polyether ether ketone (PEEK); polyethylene (PE); polyurethane; polyolefin copolymer (POC); tetrafluoroethylenes, such as polytetrafluoroethylene (PTFE).
Other suitable materials include steel, including laser cut stainless steel. The catheter may comprise coils as described in FIG. 9C as described in paragraphs [0101] and [0102] of U.S. Publication No. 2010/0063534, which is hereby incorporated by reference as if fully set forth herein. The catheter may comprise at least one lumen that is configured to allow supplemental treatment devices access to the interior of the lumen.
Another embodiment of the invention is directed towards a method for crossing an obstruction in blood vessel. The method includes advancing a first guide wire through a true lumen of vessel and into an interstitial space of the vessel. In some instances with severe calcification present, an undersized low profile balloon or other intervention dilation device may be used to pre-dilate the subintimal space prior to introduction of the reentry catheter. Next, the reentry catheter is advanced into the subintimal space through either an over the wire or via a rapid exchange technique with the reentry member in a stowed position. The catheter then advances through the subintimal space until the lateral port is distal to the total occlusion.
The orientation and the location of the catheter and its lateral port with respect to the occlusion may be directed through the use of radiopaque markers and visualization techniques known in the art. Once the catheter has been properly oriented, the operator moves the reentry member from the stowed or locked position and subsequently articulates the member such that a precise incision is made between the subintimal space and the true vessel lumen. A second interventional guide wire, in the case of a rapid exchange catheter, or the first guide wire for an over the wire configuration is advanced into the vessel lumen through the hollow portion of the reentry member. Once the intervention wire is in place, the reentry member may be retracted and the entire reentry catheter removed. Of course, more than one wire may also be used in the over the wire technique.
Yet another embodiment of the invention is directed towards a kit. The kit includes a catheter according to embodiments of the invention and optionally directions for use. The kit may also include a supplemental treatment device, e.g., a balloon, optical catheter, visualization catheter, stent, embolic protection device and the like. In addition, the kit may include valves and other devices that may be used in medical procedures.
Referring to
The catheter 100 is flexible and has a proximal end 102 and a distal end 104. The proximal end 102 is attached to a handle (not shown). A shaft 106 extends from the proximal end 102 of the catheter to the distal end of a rigid shroud or cover 108. The shaft 106 may be constructed of conventional techniques. In a preferred embodiment, the shaft includes braided, double braided, or by triplex construction as described in U.S. Patent Application No. 61/503,477, which is hereby incorporated by reference. A lateral port 110 is located near the distal end 104 and preferably in the rigid shroud 108. Alternatively, or in addition to, a lateral port (not shown) may also be located in the shaft 106. The shaft 106 includes at least one lumen 114 extending at least partially along the entire shaft 106 and exiting out the catheter distal end 104. In some embodiments, the lumen 114 may be used to provide supplemental treatment devices to the distal tip of the catheter 100.
The distal end of shaft 106 is connected to the proximal end of shroud 108 preferably by a laser weld, glue, over-molding or the like as known in the art. There may be more than one lateral port at a distal portion of the shroud 108.
Optionally, a flexible atraumatic tip 116 may be attached to the distal end of the shroud 108 preferably by a laser weld, glue, over-molding or the like as known in the art. Alternatively, the shroud or cover 108 may extend to the catheter distal end 104 and be formed with an atraumatic tip profile. Further, an over molded distal extension (not shown) of the catheter may be incorporated to provide additional support during device orientation and during launch of the reentry member 112. The reentry member 112 is docked in a straight position, as shown in
At least one marker, e.g., a radiopaque marker, 118 is disposed on the body of the catheter near its distal end or integrated within the body of the catheter. The radiopaque marker 118 is used with standard visualization techniques, e.g. fluoroscopy, to guide the catheter through the body and into position in the subintimal space, to position the lateral port 110 and reentry member 112 at a desired location distal to the occlusion, and to determine whether the reentry member 12 is in the stowed, ready, or in a fully articulated position. Radiopaque markers as described in U.S. Patent Application Ser. No. 61/503,477, U.S. Patent Application 2010/0317973, U.S. Pat. No. 6,544,230, 6,719,725, or 6,231,546 may also be used, which are hereby incorporated by reference as if fully set forth herein.
The reentry member 112 may be configured to permit other devices or supplemental devices to be operated through the lumen of the member 112. The supplemental devices may include a balloon, a cutting device, thrombectomy device, a guide wire, a filters, e.g., an embolic filter, optical devices, e.g., RF or laser ablation devices, combinations and the like. In addition, the reentry member 112 may be configured to have a predetermined shape, i.e., pre-resilient shape, straight shape, curved shaped, memory shape.
In a preferred embodiment, the lumen of the reentry member 112 is sized to accommodate a wide range of guide wire diameters such as guide wire diameters in a range from about 0.01 inches to about 0.04 inches or larger. Referring to
Referring to
At least one portion of the bottom distal edge of the reentry member 112 is formed with a sharp leading edge 126. The reentry member 112 is hollow with a lumen 128 that is continuous with catheter lumen 114. The cut out or void 124 may also be spaced at various locations around the circumference of the reentry member 112 relative to a leading edge 126, e.g., about 2 degrees to about 180 degrees. In a preferred embodiment, the center of the cut out or void 124 is about 180 degrees relative to a leading edge 126. A sharp edge 156 at distal tip 158 of the reentry member 112 may also be utilized in this embodiment.
Referring to
Referring to
In another embodiment, the control wire 130 may be the guide wire 120 configured to attach to distal portion of the reentry member 112, for example with a hook on the end of the guide wire 120.
During reentry, an operator would mechanically control the reentry member 112 by holding the catheter 100 in place and by pulling the control wire 130 as shown with the arrow in
The control wire may be comprised of at least one tendon, tether, coil, cable, linkage and made of a suitably flexible material capable of withstanding a high tension load such as Kevlar, Nylon, Nitinol, biocompatible metal wire, or other material known in the art.
Referring to
During reentry, an operator would control the reentry member 112 by holding the catheter 100 in place and pushing the reentry member 112 in the direction of the arrow 140. The pushing force is configured to provide the necessary force to curve or flex the distal end of reentry member 112 from a first orientation, e.g., parallel to the vessel wall to a second orientation between about 0 and about 180 degrees of the vessel wall and more preferably between about 5 and about 90 degrees with respect to the vessel wall. Thereby, allowing a leading edge 156 of the reentry member 112 to penetrate the vessel wall and reenter a true lumen of the vessel. Alternatively the control wire 130 in
Referring to
After inflation of the balloon 142 the reentry member 112 moves to a second position or a non-stowed position. More specifically, the non-compliant balloon 142 exerts an eccentric load on the top edge of the reentry member 112 to deliver the necessary force to curve or flex the distal portion of the reentry member 112 from an orientation about parallel to the vessel wall to an orientation between about 0 and about 180 degrees of the vessel wall and more preferably between about 5 and about 90 degrees with respect to the vessel wall.
After articulated to a predetermined position, the entire catheter body, if necessary, may be pulled proximally causing the intimal tissue to be forced against the sharp leading edge 156 creating a subintimal arteriotomy. This action may be controlled mechanically using the controls integrated in the proximal handle (not shown). The distal tip of the reentry member 112 would then be inside the true lumen of the vessel and a guide wire 120 or supplementary intervention device may be passed through the central lumen of the reentry member 112.
The catheter 200 is flexible and has a proximal end 202 and a distal end 204. The proximal end 202 is attached to a handle (not shown). A shaft 206 extends from the proximal end 202 of the catheter to the distal end of a rigid shroud. The shaft 206 may be constructed of conventional techniques, e.g. braided or double braided, or by triplex construction as described herein. A lateral port 210 is located near the distal end and preferably in the rigid shroud. Alternatively, or in addition to, a lateral port (not shown) may also be located in the shaft 206. The shaft 206 includes a lumen 214 extending at least partially along the entire shaft 206.
A reentry member 212 may be contained in the inner lumen of shaft 206 along substantially the length of catheter 200. In some embodiments, the reentry member 212 is hollow and allows for an optional second guide wire, cannula or other supplemental treatment device 224. The distal end 204 of shaft 206 is connected to the proximal end of shroud preferably by a laser weld, glue, over-molding or the like as known in the art. There may be more than one lateral port at a distal portion of the shroud. Optionally, a flexible atraumatic tip 216 may be attached to the distal end of the shroud preferably by a laser weld, glue, over-molding or the like as known in the art. Alternatively, the shroud may extend to the catheter distal end 204 be formed with an atraumatic tip profile.
Further, an overmolded distal extension (not shown) of the catheter may be added to a distal end of the catheter 200 as described in U.S. Patent Application No. 61/503,477, which is hereby incorporated by reference as if fully set forth herein. The over molded distal extension is configured to provide additional support during device orientation and during launch of the reentry member 212. The reentry member 212 is docked in a straight position, while traversing through an artery and into or out of the subintimal vessel space. Alternatively, a retractable shroud cover (not shown) may be used to protect the vessel during catheter transport through the body. The reentry member 212 may be mechanically controlled through the use of a tension member, a tether member or a balloon as described herein. Optionally, an additional lumen may be contained within the catheter 200 that may be used for supplemental treatment devices.
The catheter 200 optionally may include at least one radiopaque marker 218. In a preferred embodiment, the radiopaque markers are configured to ensure orientation of the lateral port towards the true lumen of the vessel. The radiopaque markers may also be configured to determine a spatial relationship of other attributes of the catheter, e.g., the spatial location of the distal end of the catheter, confirmation of the stowed position of the reentry member, etc. In a preferred embodiment, at least one marker 218 is arranged near a distal portion of the catheter.
Referring to
Referring to
Referring to
Once the catheter 100 is in position at a location distal to the occlusion 806 and the lateral port 110 and the reentry member 112 are oriented to articulate and launch into the true vessel lumen, the operator retracts the guide wire 802 to a position within the reentry member, as shown in
Alternatively for a rapid exchange configuration as described in
The activation mechanism may be linked to a simple handle (not shown) such that the operator either rotates a knob or activates a mechanical or electro-mechanical control element to transition from a ready to an articulated of flexed configuration. The guide wire 802 or another appropriate device may be passed through the shaft lumen 214 and the lumen of the reentry member 212 and into the true vessel lumen. The intervention guide wire may be sized from about 0.10 inches to about 0.40 inches or larger and may contain a lubricous coating as known in the art.
The reentry member 212 reenters the vessel lumen at an angle in a range from about 5 degrees to about 180 degrees, more preferably at an angle in range from about between about 5 degrees to about 90 degrees. The sharp edge 156 and/or 126 on the reentry member dissects the vessel wall from the subintimal space 804 into the true vessel lumen. The cutting action significantly reduces the force required to safely and accurately reenter the vessel lumen even in the presence of calcified tissue. This reentry force is significantly lower than the forces required for known reentry devices, which require lateral extension of the catheter and improved torsional control to support reentry forces. During reentry, the vessel wall tends to pull away from a more traditional reentry cannula tip during reentry such that penetration will require an increased force application and possible multiple attempts to successfully enter the lumen. The use of a reentry member overcomes this challenge posed by the prior art and allows the operator to reenter at their preferred location easily and repeatedly. Moreover, it is thought that the use of the reentry member results in more consistent reentry at a location closer to the distal point of the occlusion 806 as compared to the use of a simple curved cannula as known in the art.
Referring to
It will be apparent to those skilled in the art that various modifications and variation can be made in the present invention without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.
This application is a continuation of U.S. patent application Ser. No. 14/631,592, filed Feb. 25, 2015, now U.S. Pat. No. 9,775,969, which is a continuation of U.S. patent application Ser. No. 13/229,392, filed Sep. 9, 2011, now U.S. Pat. No. 8,998,936, which claims the benefit of U.S. Provisional Patent Application No. 61/503,477, filed on Jun. 30, 2011. The above applications are hereby incorporated by reference for all purposes as if fully set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
3853004 | Cebuliak et al. | Dec 1974 | A |
4227293 | Taylor | Oct 1980 | A |
4552554 | Gould et al. | Nov 1985 | A |
4664112 | Kensey et al. | May 1987 | A |
4712547 | Bonnet | Dec 1987 | A |
4774949 | Fogarty | Oct 1988 | A |
4784636 | Rydell | Nov 1988 | A |
4926858 | Gifford et al. | May 1990 | A |
4994067 | Summers | Feb 1991 | A |
5047040 | Simpson et al. | Sep 1991 | A |
5053044 | Mueller et al. | Oct 1991 | A |
5066288 | Deniega et al. | Nov 1991 | A |
5092872 | Segalowitz | Mar 1992 | A |
5100426 | Nixon | Mar 1992 | A |
5104382 | Brinkerhoff et al. | Apr 1992 | A |
5135531 | Shiber | Aug 1992 | A |
5234450 | Segalowitz | Aug 1993 | A |
5242461 | Kortenbach et al. | Sep 1993 | A |
5279551 | James | Jan 1994 | A |
5287861 | Wilk | Feb 1994 | A |
5308354 | Zacca et al. | May 1994 | A |
5334211 | Shiber | Aug 1994 | A |
5336176 | Yoon | Aug 1994 | A |
5391177 | Schwartz | Feb 1995 | A |
5409019 | Wilk | Apr 1995 | A |
5413581 | Goy | May 1995 | A |
5423846 | Fischell | Jun 1995 | A |
5429497 | Yamada et al. | Jul 1995 | A |
5443443 | Shiber | Aug 1995 | A |
5443497 | Venbrux | Aug 1995 | A |
5512044 | Duer | Apr 1996 | A |
5536251 | Evard et al. | Jul 1996 | A |
5558665 | Kieturakis | Sep 1996 | A |
5596990 | Yock et al. | Jan 1997 | A |
5601588 | Tonomura et al. | Feb 1997 | A |
5628761 | Rizik | May 1997 | A |
5632755 | Nordgren et al. | May 1997 | A |
5643298 | Nordgren et al. | Jul 1997 | A |
5649941 | Lary | Jul 1997 | A |
5651781 | Grace | Jul 1997 | A |
5658311 | Baden | Aug 1997 | A |
5690664 | Sauer et al. | Nov 1997 | A |
5695469 | Segal | Dec 1997 | A |
5702390 | Austin et al. | Dec 1997 | A |
5724977 | Yock et al. | Mar 1998 | A |
5728129 | Summers | Mar 1998 | A |
5746758 | Nordgren et al. | May 1998 | A |
5776154 | Taylor et al. | Jul 1998 | A |
5830222 | Makower | Nov 1998 | A |
5836868 | Ressemann et al. | Nov 1998 | A |
5841893 | Ishikawa et al. | Nov 1998 | A |
5879305 | Yock et al. | Mar 1999 | A |
5902263 | Patterson et al. | May 1999 | A |
5935108 | Katoh et al. | Aug 1999 | A |
5938671 | Katoh et al. | Aug 1999 | A |
5941893 | Saadat | Aug 1999 | A |
5951567 | Javier et al. | Sep 1999 | A |
5972019 | Engelson et al. | Oct 1999 | A |
6024730 | Pagan | Feb 2000 | A |
6027514 | Stine et al. | Feb 2000 | A |
6066149 | Samson et al. | May 2000 | A |
6080171 | Keith et al. | Jun 2000 | A |
6080175 | Hogendijk | Jun 2000 | A |
6081738 | Hinohara et al. | Jun 2000 | A |
6096054 | Wyzgala et al. | Aug 2000 | A |
6155264 | Ressemann et al. | Dec 2000 | A |
6190353 | Makower et al. | Feb 2001 | B1 |
6196230 | Hall et al. | Mar 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6221049 | Selmon et al. | Apr 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6235000 | Milo et al. | May 2001 | B1 |
6238406 | Ellis et al. | May 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6402778 | Wang | Jun 2002 | B2 |
6419659 | Phelps et al. | Jul 2002 | B1 |
6419685 | Di Caprio et al. | Jul 2002 | B2 |
6432129 | DiCaprio | Aug 2002 | B2 |
6475226 | Belef et al. | Nov 2002 | B1 |
6488693 | Gannoe et al. | Dec 2002 | B2 |
6506178 | Schubart et al. | Jan 2003 | B1 |
6506200 | Chin | Jan 2003 | B1 |
6506201 | Di Caprio et al. | Jan 2003 | B2 |
6511458 | Milo et al. | Jan 2003 | B2 |
6533753 | Haarstad et al. | Mar 2003 | B1 |
6533755 | Adams | Mar 2003 | B2 |
6544230 | Flaherty et al. | Apr 2003 | B1 |
6569129 | Holmes et al. | May 2003 | B1 |
6579302 | Duerig et al. | Jun 2003 | B2 |
6589274 | Stiger et al. | Jul 2003 | B2 |
6592568 | Campbell | Jul 2003 | B2 |
6596005 | Kanz et al. | Jul 2003 | B1 |
6602225 | Eidenschink et al. | Aug 2003 | B2 |
6655386 | Makower et al. | Dec 2003 | B1 |
6663577 | Jen et al. | Dec 2003 | B2 |
6676667 | Mareiro et al. | Jan 2004 | B2 |
6702777 | Haim et al. | Mar 2004 | B2 |
6719725 | Milo et al. | Apr 2004 | B2 |
6736841 | Musbach et al. | May 2004 | B2 |
6796963 | Carpenter et al. | Sep 2004 | B2 |
6808531 | Lafontaine et al. | Oct 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6881216 | Di Caprio et al. | Apr 2005 | B2 |
6890348 | Sydney et al. | May 2005 | B2 |
6923827 | Campbell et al. | Aug 2005 | B2 |
6942681 | Johnson | Sep 2005 | B2 |
7004173 | Sparks et al. | Feb 2006 | B2 |
7056323 | Mareiro et al. | Jun 2006 | B2 |
7083639 | Guinan et al. | Aug 2006 | B2 |
7137990 | Hebert et al. | Nov 2006 | B2 |
7147655 | Chermoni | Dec 2006 | B2 |
7172575 | El-Nounou et al. | Feb 2007 | B2 |
7172621 | Theron | Feb 2007 | B2 |
7175607 | Lim et al. | Feb 2007 | B2 |
7179270 | Makower | Feb 2007 | B2 |
7201770 | Johnson et al. | Apr 2007 | B2 |
7226472 | Pederson et al. | Jun 2007 | B2 |
7273485 | Simpson et al. | Sep 2007 | B2 |
7314588 | Blankenship | Jan 2008 | B2 |
7329267 | Weber | Feb 2008 | B2 |
7344557 | Yadin | Mar 2008 | B2 |
7399291 | Vo et al. | Jul 2008 | B2 |
7476214 | Sydney et al. | Jan 2009 | B2 |
7553324 | Andreas et al. | Jun 2009 | B2 |
7572270 | Johnson | Aug 2009 | B2 |
7604621 | Eidenschink | Oct 2009 | B2 |
7632288 | Wu | Dec 2009 | B2 |
7951186 | Eidenschink et al. | May 2011 | B2 |
8956376 | Alvarez et al. | Feb 2015 | B2 |
8998936 | Alvarez et al. | Apr 2015 | B2 |
9814862 | Alvarez et al. | Nov 2017 | B2 |
20010000041 | Selmon et al. | Mar 2001 | A1 |
20010014821 | Juman et al. | Aug 2001 | A1 |
20010029387 | Wolf et al. | Oct 2001 | A1 |
20010031981 | Evans et al. | Oct 2001 | A1 |
20010034547 | Hall et al. | Oct 2001 | A1 |
20020103459 | Sparks et al. | Aug 2002 | A1 |
20030014100 | Maria Meens et al. | Jan 2003 | A1 |
20030032999 | Huang | Feb 2003 | A1 |
20030109809 | Jen et al. | Jun 2003 | A1 |
20030171799 | Lee et al. | Sep 2003 | A1 |
20030236542 | Makower | Dec 2003 | A1 |
20040044392 | Von Oepen | Mar 2004 | A1 |
20040170782 | Wang et al. | Sep 2004 | A1 |
20040181252 | Boyle et al. | Sep 2004 | A1 |
20040230219 | Roucher | Nov 2004 | A1 |
20050004649 | Mistry et al. | Jan 2005 | A1 |
20050021002 | Deckman et al. | Jan 2005 | A1 |
20050027248 | Suzuki et al. | Feb 2005 | A1 |
20050038382 | Miller et al. | Feb 2005 | A1 |
20050049574 | Petrick et al. | Mar 2005 | A1 |
20050049672 | Murphy | Mar 2005 | A1 |
20050055078 | Campbell | Mar 2005 | A1 |
20050059938 | Malisch | Mar 2005 | A1 |
20050075711 | Neary | Apr 2005 | A1 |
20050085845 | Hilaire et al. | Apr 2005 | A1 |
20050085889 | Sundar | Apr 2005 | A1 |
20050090853 | Duchamp | Apr 2005 | A1 |
20050090888 | Hines et al. | Apr 2005 | A1 |
20050096722 | Lootz et al. | May 2005 | A1 |
20050102020 | Grayzel et al. | May 2005 | A1 |
20050107819 | Sater | May 2005 | A1 |
20050118370 | Varma et al. | Jun 2005 | A1 |
20050119731 | Brucker et al. | Jun 2005 | A1 |
20050131444 | Ricci | Jun 2005 | A1 |
20050171478 | Selmon et al. | Aug 2005 | A1 |
20050209559 | Thornton et al. | Sep 2005 | A1 |
20050271844 | Mapes et al. | Dec 2005 | A1 |
20050273021 | Burgermeister | Dec 2005 | A1 |
20050273149 | Tran et al. | Dec 2005 | A1 |
20050273153 | Clerc et al. | Dec 2005 | A1 |
20050277979 | Dorros et al. | Dec 2005 | A1 |
20050278011 | Peckham | Dec 2005 | A1 |
20050288629 | Kunis | Dec 2005 | A1 |
20060009737 | Whiting et al. | Jan 2006 | A1 |
20060009832 | Fisher | Jan 2006 | A1 |
20060015133 | Grayzel et al. | Jan 2006 | A1 |
20060025843 | Gurm et al. | Feb 2006 | A1 |
20060030922 | Dolan | Feb 2006 | A1 |
20060030924 | Van Der Leest et al. | Feb 2006 | A1 |
20060047336 | Gale et al. | Mar 2006 | A1 |
20060074476 | Holman et al. | Apr 2006 | A1 |
20060085058 | Rosenthal et al. | Apr 2006 | A1 |
20060106448 | Shaked | May 2006 | A1 |
20060129179 | Weber et al. | Jun 2006 | A1 |
20060135909 | Holman et al. | Jun 2006 | A1 |
20060173440 | Lamson et al. | Aug 2006 | A1 |
20060184186 | Noone | Aug 2006 | A1 |
20060235458 | Belson | Oct 2006 | A1 |
20060276749 | Selmon et al. | Dec 2006 | A1 |
20070021685 | Oepen et al. | Jan 2007 | A1 |
20070088230 | Terashi | Apr 2007 | A1 |
20070093780 | Kugler et al. | Apr 2007 | A1 |
20070208368 | Katoh et al. | Sep 2007 | A1 |
20070250036 | Volk et al. | Oct 2007 | A1 |
20070265563 | Heuser | Nov 2007 | A1 |
20070276419 | Rosenthal | Nov 2007 | A1 |
20080097247 | Eskuri | Apr 2008 | A1 |
20080114390 | Guinan | May 2008 | A1 |
20080125748 | Patel | May 2008 | A1 |
20080140101 | Carley et al. | Jun 2008 | A1 |
20080154172 | Mauch | Jun 2008 | A1 |
20080228171 | Kugler et al. | Sep 2008 | A1 |
20080234717 | Bruszewski | Sep 2008 | A1 |
20080243065 | Rottenberg et al. | Oct 2008 | A1 |
20080243067 | Rottenberg et al. | Oct 2008 | A1 |
20080249465 | Ryder et al. | Oct 2008 | A1 |
20090088685 | Kugler et al. | Apr 2009 | A1 |
20090093829 | Melsheimer et al. | Apr 2009 | A1 |
20090124857 | Viola | May 2009 | A1 |
20090171430 | Baim et al. | Jul 2009 | A1 |
20090209910 | Kugler et al. | Aug 2009 | A1 |
20090234378 | Escudero et al. | Sep 2009 | A1 |
20090270888 | Patel et al. | Oct 2009 | A1 |
20100063534 | Kugler et al. | Mar 2010 | A1 |
20100286626 | Petersen et al. | Nov 2010 | A1 |
20100317973 | Nita | Dec 2010 | A1 |
20130006167 | Alvarez et al. | Jan 2013 | A1 |
20140371718 | Alvarez et al. | Dec 2014 | A1 |
20150119910 | Alvarez et al. | Apr 2015 | A1 |
20180043134 | Alvarez et al. | Feb 2018 | A1 |
Number | Date | Country |
---|---|---|
0166212 | Jan 1986 | EP |
2006181370 | Jul 2006 | JP |
9713471 | Apr 1997 | WO |
1997013463 | Apr 1997 | WO |
2008005888 | Jan 2008 | WO |
2013003757 | Jan 2013 | WO |
Entry |
---|
U.S. Appl. No. 15/227,800 entitled Reentry Catheter and Method Thereof, filed Aug. 3, 2016. |
U.S. Appl. No. 14/631,592, filed Feb. 25, 2015. |
U.S. Appl. No. 13/229,392, filed Sep. 9, 2011. |
Belli et al., “Peripheral Vascular Occlusions: Mechanical Recanalization with a Metal Laser Probe after Guide Wire Dissection,” Radiology, vol. 176, No. 2, pp. 539-541, Aug. 1990. |
Bolia et al., “Percutaneous Extraluminal (Subintimal) Recanalization of a Brachial Artery Occlustion Following Cardiac Catheterization,” Cardiovascular and Interventional Radiology, vol. 19, pp. 184-186, 1996. |
Bolia et al., “Percutaneous Transluminal Angioplasty of Occlusions of the Femoral and Popliteal Arteries by Subintimal Dissection,” Cardiovascular and Interventional Radiology, vol. 13, pp. 357-363, 1990. |
Bolia et al., “Recanalisation of Femora-Popliteal Occlusions: Improving Success Rate by Subintimal Recanalisation,” correspondence to the editor, Clinical Radiology, vol. 40, No. 3, p. 325, May 1989. |
Bolia et al., “Recanalization of Iliac Artery Occlusion by Subintimal Using the Ipsilateral and the Contralateral Approach,” Clinical Radiology, vol. 52, pp. 684-687, 1997. |
Bolia et al., “Subintimal and Intraluminal Recanalisation of Occluded Crural Arteries by Percutaneous Balloon Angioplasty,” European Journal of Vascular Surgery, vol. 8, pp. 214-219, 1994. |
Braun, “Guide Wire-assisted Placement of Non-End-Hole Nasoenteric Feeding Tubes,” Radiology, p. 606, Feb. 2000. |
Glasby et al., “Subintimal angioplasty,” C212, 2008, vol. VI(1), pp. 12-16. |
Heenan et al., “Clinics in Interventional Radiology: Percutaneous Transluminal Angioplasty by a Retrograde Subintimal Transpopliteal Approach,” Clinical Radiology, vol. 49, pp. 824-828, 1994. |
International Search Report and Written Opinion issued in PC/US2012/052858 dated Jan. 25, 2013, 10 pages. |
International Search Report and Written Opinion issued in PCT/US2012/045011 dated Jan. 7, 2013, 10 pages. |
International Search Report and Written Opinion issued in PCT/US2012/052852 dated Nov. 2, 2012, 8 pages. |
Mathis et al., “Use of a Guide Catheter as a Temporary Stent during Microcatheter Intervention,” American Journal of Neurpradiology, vol. 19, pp. 932-933, May 1998. |
Miyayama et al., “Use of a Catheter with a Large Side Hole for Selective Catheterization of the Inferior Phrenic Artery,” Journal of Vascular and Interventional Radiology, vol. 12, No. 4, pp. 497-499, Apr. 2001. |
Murphy et al., “Use of a Curved Needle for True Lumen Re-entry during Subintimal Iliac Artery Revasculartzation,” Journal of Vascular and Interventional Radiology, vol. 8, No. 4, pp. 633-636, Jul.-Aug. 1997. |
Nasim et al., “Intentional Extraluminal Recanalisation of the Femoropopliteal Segment Following Perforation During Percutaneous Transluminal Angioplasty,” European Journal of Vascular and Endovascular Surgery, vol. 12, pp. 246-249, 1996. |
Nydahl et al., “Subintimal Angioplasty of Infrapopliteal Occlusions in Critically Ischaemic Limbs,” European Journal of Vascular and Endovascular Surgery, vol. 14, pp. 212-216, 1997. |
Office Action issued for U.S. Appl. No. 13/229,378 dated Sep. 6, 2013, 10 pages. |
Office Action issued in U.S. Appl. No. 13/229,392 dated Nov. 7, 2013, 10 pages. |
Reekers et al., “Percutaneous intentional extraluminal (subintimal) recanalization: How to do it yourself,” European Journal of Radiology, vol. 28, pp. 192-198, 1998. |
Reekers et al., “Percutaneous Intentional Extraluminal Recanalisation of the Femoropopliteal Artery,” European Journal of Vascular Surgery, vol. 8, pp. 723-728, 1994. |
Won et al., “Microcatheter Placement through a Side Hole Created in a 5-F Catheter Into Proximal Subclavian Arterial Branches Causing Hemoptysis,” Journal of Vascular and Interventional Radiology, vol. 15, No. 8, pp. 881-884, Aug. 2004. |
Number | Date | Country | |
---|---|---|---|
20180056041 A1 | Mar 2018 | US |
Number | Date | Country | |
---|---|---|---|
61503477 | Jun 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14631592 | Feb 2015 | US |
Child | 15677791 | US | |
Parent | 13229392 | Sep 2011 | US |
Child | 14631592 | US |